Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Abbott LAA Occluder Gains CE Mark for AFib Stroke Risk Reduction

By HospiMedica International staff writers
Posted on 28 Aug 2026

Atrial fibrillation increases stroke risk because blood clots often form in the left atrial appendage. More...

For patients who cannot tolerate long-term anticoagulation, minimally invasive closure can provide an alternative, but achieving durable and complete sealing across varied appendage anatomies remains challenging. A new device now offers a conformable, dual-seal implant designed to improve left atrial appendage closure and potentially reduce reliance on blood thinners.

Abbott’s Amulet 360 Left Atrial Appendage (LAA) Occluder has received CE Mark for reducing stroke risk in people with non-valvular atrial fibrillation (AFib). Following approval, the first European procedures were completed at the Cardiovascular Clinic Bethanien in Frankfurt, the University Heart Center in Lübeck, and Aarhus University Hospital, with broader availability across European countries planned in the coming weeks. The LAA is a small, structurally complex pouch attached to the left atrium and is a common site of thrombus formation in AFib, making it a key target for stroke prevention.

Amulet 360 employs a two-component, dual-seal design. Its redesigned body, or lobe, is softer and more conformable than the prior-generation occluder to accommodate a wider range of appendage anatomies, and it uses smaller anchors to secure the implant within the LAA. An outer disk provides a second sealing layer to help close the appendage, with the combined construct intended to prevent clot embolization. The device is delivered via a minimally invasive venous approach to immediately close the LAA and can potentially eliminate the need for blood-thinning medication when clinically appropriate.

Regulatory approval in Europe was supported by early clinical experience. The device remains approved for investigational use only in the United States. Within Abbott’s electrophysiology portfolio, the approval follows several recent system clearances in Europe and the U.S.

Clinical evidence includes the VERITAS Study of 400 patients across more than 30 hospitals in the U.S., Canada, and Europe. At 45 days, implantation was successful in 99.8% of patients and early safety benchmarks were met, with no reported complications such as additional surgery, strokes, or blood clots within seven days of implantation. Complete LAA closure without leaks greater than 3 mm was achieved in 93.9% of implanted patients.

“With Amulet 360, doctors can help protect more people with AFib from stroke by confidently closing the left atrial appendage. By helping doctors treat a wider range of anatomies, this next-generation device has the potential to improve outcomes and help more people benefit from stroke prevention across Europe,” said Xavier Freixa, M.D., Ph.D., at Hospital Clínic de Barcelona, Spain, and a globally recognized interventional cardiologist.

“Amulet 360 builds on the proven legacy of our unique dual-seal design seen in the first-generation LAA occluder, which helped many people with AFib reduce their risk of stroke without the need for long-term blood thinners. As the latest addition to Abbott's growing portfolio of stroke prevention technologies, Amulet 360 reflects our commitment to advancing treatment options and improving outcomes for patients around the world,” said Christopher Piorkowski, M.D., chief medical officer of Abbott's electrophysiology business.


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Examination & Procedure Light
Vega 80
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: iStock

Updated Head Injury Guidelines Support Risk-Based CT and Observation Decisions

Head injuries are a common reason for emergency department visits, with most cases classified as mild. However, clinicians must identify patients at risk of intracranial bleeding or other serious injuries... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.